15.03
price up icon1.55%   0.23
after-market Dopo l'orario di chiusura: 15.24 0.21 +1.40%
loading
Precedente Chiudi:
$14.80
Aprire:
$14.93
Volume 24 ore:
1.73M
Relative Volume:
0.84
Capitalizzazione di mercato:
$23.91B
Reddito:
$30.08B
Utile/perdita netta:
$710.16M
Rapporto P/E:
68.88
EPS:
0.2182
Flusso di cassa netto:
$4.45B
1 W Prestazione:
+3.16%
1M Prestazione:
-1.64%
6M Prestazione:
+10.35%
1 anno Prestazione:
+15.35%
Intervallo 1D:
Value
$14.88
$15.04
Intervallo di 1 settimana:
Value
$14.51
$15.04
Portata 52W:
Value
$12.57
$15.43

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Name
Nome
Takeda Pharmaceutical Co Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
49,281
Name
Cinguettio
@takedapharma
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
TAK's Discussions on Twitter

Confronta TAK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-02 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-03-16 Aggiornamento BofA Securities Neutral → Buy
2022-07-19 Aggiornamento Cowen Market Perform → Outperform
2021-10-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-04-19 Downgrade JP Morgan Overweight → Neutral
2019-11-01 Iniziato Cowen Market Perform
2019-08-15 Downgrade Daiwa Securities Outperform → Neutral
Mostra tutto

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

pulisher
May 28, 2025

Takeda files executive compensation report with SEC - Investing.com

May 28, 2025
pulisher
May 22, 2025

Cameco Earns Relative Strength Rating Upgrade; Hits Key Threshold - inkl

May 22, 2025
pulisher
May 20, 2025

Takeda Pharmaceutical ADR Shows Rising Relative Strength; Still Shy Of Key Threshold - inkl

May 20, 2025
pulisher
May 19, 2025

Fidelity Natl Info Svcs Shows Rising Relative Strength; Still Shy Of Key Benchmark - inkl

May 19, 2025
pulisher
May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025
pulisher
May 09, 2025

Financial Metrics Unveiled: Topgolf Callaway Brands Corp (MODG)’s Key Ratios in the Spotlight - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratios Reveal: Breaking Down Takeda Pharmaceutical Co ADR (TAK)’s Financial Health - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Insights: Nuveen Churchill Direct Lending Corp (NCDL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 08, 2025

Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs - Benzinga

May 08, 2025
pulisher
May 02, 2025

TAK or DSNKY: Which Is the Better Value Stock Right Now? - Yahoo Finance

May 02, 2025
pulisher
May 01, 2025

Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction - knoxdaily.com

May 01, 2025
pulisher
Apr 28, 2025

Takeda Pharmaceutical Co ADR [TAK] Insider Activity: An Update for Investors - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Takeda Pharmaceutical Co ADR (TAK) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Nothing is Better Than C.H. Robinson Worldwide, Inc (CHRW) stock at the moment - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Takeda Pharmaceutical Co ADR Inc. (TAK) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Carmax Inc: Analyzing KMX Stock Trends - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Klaviyo Inc (KVYO) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

You might want to take a look at Denison Mines Corp (DNN) now - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

A Look at Cousins Properties Inc (CUZ) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

A better buy-in window may exist right now for Cheesecake Factory Inc (CAKE) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Stocks of CN Energy Group Inc (CNEY) are poised to climb above their peers - Sete News

Apr 25, 2025
pulisher
Apr 22, 2025

Analyzing Takeda Pharmaceutical Co ADR (TAK) After Recent Trading Activity - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Cintas Corporation [CTAS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 22, 2025
pulisher
Apr 16, 2025

TAK vs. DSNKY: Which Stock Is the Better Value Option? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Organon expands board with new director from Takeda - Investing.com

Apr 15, 2025
pulisher
Apr 09, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN

Apr 09, 2025
pulisher
Apr 03, 2025

Asian ADRs Take A Hit As S&P Asia 50 Dips - Finimize

Apr 03, 2025
pulisher
Apr 02, 2025

Morgan Stanley lifts Takeda stock rating, raises target to JPY5,500 - Investing.com

Apr 02, 2025
pulisher
Mar 31, 2025

TAK vs. DSNKY: Which Stock Should Value Investors Buy Now? - Yahoo

Mar 31, 2025
pulisher
Mar 14, 2025

PD Stock on the Rise: A Promising Investment - The InvestChronicle

Mar 14, 2025
pulisher
Mar 14, 2025

Vital Energy Inc (VTLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Mar 14, 2025
pulisher
Mar 14, 2025

China Liberal Education Holdings Ltd: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle

Mar 14, 2025
pulisher
Mar 14, 2025

Takeda Pharmaceutical Stock (NYSE: TAK): Strategic Focus on Oncology and Growth Opportunities - Value the Markets

Mar 14, 2025
pulisher
Mar 13, 2025

Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds - Seeking Alpha

Mar 13, 2025
pulisher
Mar 06, 2025

Charles Schwab Trying To Close In On Key Technical Measure - Inkl

Mar 06, 2025
pulisher
Mar 04, 2025

Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Mar 04, 2025
pulisher
Mar 04, 2025

Takeda Pharmaceutical ADR Trying To Close In On Key Technical Measure - Investor's Business Daily

Mar 04, 2025

Takeda Pharmaceutical Co Adr Azioni (TAK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$16.78
price down icon 4.28%
$1.79
price up icon 1.70%
$318.85
price down icon 0.47%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$123.02
price down icon 0.52%
Capitalizzazione:     |  Volume (24 ore):